This study is designed to test how well a new drug, RO7795081, works for adults with Type 2 Diabetes, compared to a placebo (a "fake" drug with no medicine) or another diabetes drug, Semaglutide. **Type 2 Diabetes** is when your body has trouble using sugar for energy, leading to high blood sugar levels. The study checks if RO7795081 is safe and helps control blood sugar.

To join, you must have had Type 2 Diabetes for at least 6 months, with blood sugar levels (measured as HbA1c) between 7% and 10.5%. You should be managing diabetes with diet, exercise, or specific medications like Metformin or SGLT-2 inhibitors. You should also have a stable body weight and BMI of 23 or more.

**Key Points**:

• The study compares different doses of RO7795081 with a placebo or Semaglutide.
• Participants must have Type 2 Diabetes and meet specific health criteria.
• Those with other types of diabetes or certain health issues cannot participate.